Clinical Trials
22 trialsNCT01149850 2024-09-19
Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
Jonsson Comprehensive Cancer Center
Phase 2 Completed
NCT00499291 2023-05-25
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
Eastern Cooperative Oncology Group
Phase NA Withdrawn
NCT00770471 2018-06-27
ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00686842 2018-06-06
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
AIDS Malignancy Consortium
Phase 1/2 Terminated
NCT01390571 2018-02-05
Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma
Cancer Research UK
Phase 1 Completed
NCT00897663 2018-01-24
Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies
Alliance for Clinical Trials in Oncology
Completed
NCT00730613 2017-10-09
Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma
City of Hope Medical Center
Phase 1 Completed
NCT00049504 2017-05-17
Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT01353300 2016-07-11
Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
Children's Oncology Group
Completed
NCT01365962 2016-05-19
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma
Children's Oncology Group
Completed
NCT01433237 2016-05-19
Studying Biomarkers in Samples From Patients With Rhabdomyosarcoma
Children's Oncology Group
Completed
NCT01466283 2016-05-19
Biomarkers in Patients With Rhabdomyosarcoma
Children's Oncology Group
Completed
NCT01430637 2016-05-18
Studying Genes in Samples From Younger Patients With Desmoplastic Small Round Cell Tumor Registered on COG-D9902 or COG-ABTR01B1
Children's Oncology Group
Completed
NCT01480518 2015-05-12
Biomarkers in Tissue Samples From Patients With Ewing Sarcoma
Children's Oncology Group
Completed
NCT01062438 2015-05-06
Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma
Children's Oncology Group
Completed
NCT00233948 2015-04-01
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
City of Hope Medical Center
Phase 1/2 Terminated
NCT00740597 2014-07-11
Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma
City of Hope Medical Center
Phase 2 Terminated
NCT00900341 2014-03-21
Studying Tumor Tissue Samples From Patients With Soft Tissue Sarcoma
University of Arizona
Completed
NCT00601406 2013-08-26
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
National Cancer Institute (NCI)
Phase NA Unknown
NCT00514345 2013-08-12
CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide
National Cancer Institute (NCI)
Unknown
NCT00424060 2012-09-24
Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00390403 2012-05-03
Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed